Product ID |
CAS Number |
Product Name |
Quantity |
AS-0188 |
256417-10-4 |
2,6-DIFLUORO-4-METHOXYBENZALDEHYDE |
|
AS-0711 |
78-69-3 |
Tetrahydrolinalool |
|
AS-0958 |
125995-13-3 |
(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate |
|
AS-0976 |
34160-40-2 |
6-Bromopyridine-2-carbaldehyde |
|
AS-1242 |
626-35-7 |
Ethyl nitroacetate |
|
AS-1252 |
119356-77-3 |
Dapoxetine hydrochloride |
|
AS-2693 |
3001-15-8 |
4,4'-Diiodobiphenyl |
|
AS-2704 |
8/4/5157 |
4,5-Dihydro-6-methylpyridazin-3(2H)-one |
|
AS-2706 |
5788-58-9 |
4,5-Dibromopyridazin-3-one |
|
AS-4154 |
99-93-4 |
4'-Hydroxyacetophenone |
|
AS-4160 |
10342-83-3 |
4'-Bromopropiophenone |
|
AS-4164 |
619-64-7 |
4-Ethylbenzoic acid |
|
AS-4208 |
85-41-6 |
O-Phthalimide |
|
AS-4210 |
451-82-1 |
2-Fluorophenylacetic acid |
|
AS-4224 |
543-27-1 |
Isobutyl chloroformate |
|
AS-4350 |
22223-49-0 |
Methyl 2-amino-3-methylbenzoate |
|
AS-4360 |
53903-49-4 |
2-AMINO-5-METHOXYBENZOTRIFLUORIDE |
|
AS-6870 |
13096-62-3 |
2,3,4,6-TETRA-O-BENZYL-D-GLUCONO-1,5-LACTONE |
|
AS-7211 |
592-80-3 |
5-fluoropentan-1-ol |
|
AS-7224 |
4133-35-1 |
6-Bromo-2-tetralone |
|
AS-7370 |
7251-52-7 |
Phenyl-(2-pyridyl)acetamide |
|
AS-7424 |
24677-78-9 |
2,3-Dihydroxybenzaldehyde |
|
AS-7431 |
796851-03-1 |
Pyridine, 2,5-dichloro-4-iodo- |
|
AS-7485 |
21635-88-1 |
3-OXETANAMINE |
|
AS-7645 |
39221-42-6 |
(1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-ACETIC ACID |
|
AS-7647 |
1378388-16-9 |
(2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid |
|
JR6-L2037 |
1238894-57-9 |
Benzeneethanol, 2-chloro-a-methyl-, (aS)- |
|
JR6-L2229 |
299912-80-4 |
5-Benzofuranpropanoic acid, ß-amino-2,3-dihydro-, ethyl ester, (ßS)- |
|
JR6-L2832 |
79746-67-1 |
1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-, methyl ester |
|
JR6-L6321 |
1207355-30-3 |
Dibenz[b,f]azocine-5(6H)-pentanoic acid, 11,12-didehydro-d-oxo-, methyl ester |
|
JR8-N0970 |
3371-27-5 |
GC; (-)-gallocatechin |
|
JR8-N0981 |
78432-77-6 |
Deacetyltaxol;10-Deacetyltaxol |
|
JR8-N0986 |
53-16-7 |
Estrone |
|
|
|
|
|
|
|
|
|
|
|
|
|